RESUMEN
BACKGROUND: With the worldwide use and modern development of acupuncture-moxibustion, there is disagreement on its basic definition. There has been an obstacle for clinical practice, research, and legislation. Considering this challenge, the World Federation of Acupuncture-Moxibustion Societies proposes to develop the definition and basic scope of acupuncture-moxibustion with a Delphi study. METHODS: A reactive Delphi method will be used to ask a group of experts to rate the relevance and clarity of a predesigned initial item list. This list was generated by the steering committee through a literature review and group discussion. Forty experts will be selected from many disciplines and continents to ensure appropriate representation. Predefined rules will be applied to modify the items until a consensus is achieved. After achieving the consensus on all items through the survey round, the steering committee will form the definition and basic scope of acupuncture-moxibustion by organizing a literal statement with a detailed explanation.
Asunto(s)
Terapia por Acupuntura , Técnica Delphi , Moxibustión , Terapia por Acupuntura/ética , Toma de Decisiones , Humanos , Moxibustión/ética , Encuestas y CuestionariosRESUMEN
Trigger point "dry needling" is a technique used to treat myofascial pain. It involves using filiform needles which are inserted into muscles to give local pain relief. Few cases of serious adverse events following this treatment have been reported in the literature. In this paper we describe the case of a professional swimmer who developed pneumothorax after dry needling treatment and discuss the medicolegal and ethical aspects related to competencies and responsibilities of medical doctors and physiotherapists performing the procedure.
Asunto(s)
Terapia por Acupuntura/efectos adversos , Neumotórax/etiología , Acupuntura/ética , Acupuntura/legislación & jurisprudencia , Terapia por Acupuntura/ética , Terapia por Acupuntura/instrumentación , Adulto , Humanos , Masculino , Síndromes del Dolor Miofascial/terapia , AgujasRESUMEN
In this article we discuss steps that clinicians should take after deciding to include a complementary and alternative medicine (CAM) treatment that is beyond the clinician's expertise in a patient's treatment plan. We use the example of an adolescent patient with chronic recurrent headaches that have not been relieved by medication or other therapies and whose physician refers her to an acupuncturist for treatment. We focus on (1) circumstances under which referral is appropriate, (2) the nature of the relationship between the referring clinician and the practitioner to whom the referral is made (considering conventional health care and CAM, regulated and unregulated practitioners), and (3) considerations when undertaking shared or collaborative care with other health care practitioners (conventional health care or CAM). We also suggest best practices in managing such relationships.
Asunto(s)
Terapias Complementarias , Conducta Cooperativa , Relaciones Interprofesionales , Responsabilidad Legal , Derivación y Consulta , Terapia por Acupuntura/ética , Terapia por Acupuntura/normas , Adolescente , Niño , Terapias Complementarias/ética , Terapias Complementarias/legislación & jurisprudencia , Ética Médica , Femenino , Cefalea/terapia , Humanos , Relaciones Interprofesionales/ética , Concesión de Licencias , Notificación Obligatoria , Derivación y Consulta/ética , Derivación y Consulta/legislación & jurisprudenciaRESUMEN
Although research on complementary and alternative medicine (CAM) therapies is still limited, systematic reviews have revealed sufficient evidence to conclude that CAM can be effective for certain conditions. In this article we discuss clinicians' responsibilities to inform parents/patients about CAM alternatives and use the example of acupuncture for chemotherapy-induced nausea and vomiting. Chemotherapy-induced nausea and vomiting remain significant adverse effects of cancer therapy, and some patients cannot find relief with standard therapies. When making decisions for a child with a life-threatening illness, parents must consider all reasonable options and decide what is in the child's best interests. A physician's failure to provide parents with relevant information regarding therapies with the prospect of therapeutic benefit impedes their ability to make an informed decision. Physicians have the ethical duty of beneficence; they must be aware of current research in pain and symptom management and other aspects of care. A physician's duty of care does not necessarily include the obligation to provide information about therapies outside the range of conventional treatment or those not yet supported in the medical literature. However, as CAM therapies such as acupuncture become better studied and their safety and efficacy are established, the scope of disclosure required may expand to include them. The legal and ethical obligation to obtain informed consent to treatment requires disclosure and discussion of therapies when there is reliable evidence of potential therapeutic benefit. At the same time, the more limited state of knowledge regarding effects of a particular therapy in the pediatric population must be factored into decision-making when treating a child.
Asunto(s)
Terapias Complementarias , Revelación , Consentimiento Informado , Terapia por Acupuntura/ética , Antineoplásicos/efectos adversos , Canadá , Niño , Terapias Complementarias/ética , Terapias Complementarias/legislación & jurisprudencia , Revelación/ética , Revelación/legislación & jurisprudencia , Ética Médica , Humanos , Consentimiento Informado/ética , Consentimiento Informado/legislación & jurisprudencia , Responsabilidad Legal , Masculino , Náusea/etiología , Náusea/terapia , Padres , Relaciones Médico-Paciente , Relaciones Profesional-Familia , Estados Unidos , Vómitos/etiología , Vómitos/terapiaRESUMEN
Patients and families increasingly press hospitals to facilitate provision of complementary and alternative medicine (CAM) therapies and products. At the same time, a growing number of hospitals and health care facilities have taken steps to integrate CAM and conventional care. In this article we consider institutional responsibilities when patients/parents use or are considering CAM. We (1) review hospitals' responsibilities to patients and parents, (2) explain how these principles apply in the case of CAM practitioners and products, (3) address institutional responsibilities for different models of service delivery, and (4) highlight issues that should be addressed when developing institutional policies to govern CAM use and propose ways to do so.
Asunto(s)
Terapias Complementarias , Hospitales , Responsabilidad Legal , Terapia por Acupuntura/ética , Canadá , Niño , Terapias Complementarias/economía , Terapias Complementarias/ética , Terapias Complementarias/legislación & jurisprudencia , Habilitación Profesional , Atención a la Salud/ética , Atención a la Salud/legislación & jurisprudencia , Política de Salud , Hospitales/ética , Humanos , Masculino , Servicio de Oncología en Hospital , Padres , Atención Dirigida al Paciente/ética , Atención Dirigida al Paciente/legislación & jurisprudencia , Pediatría , Relaciones Profesional-Familia , Relaciones Profesional-Paciente , Gestión de Riesgos , Estados UnidosAsunto(s)
Terapia por Acupuntura , Decepción , Efecto Placebo , Placebos/uso terapéutico , Pautas de la Práctica en Medicina/normas , Terapia por Acupuntura/ética , Ética Clínica , Ética Médica , Medicina Basada en la Evidencia , Humanos , Materia Medica/uso terapéutico , Relaciones Médico-Paciente/ética , Pautas de la Práctica en Medicina/éticaRESUMEN
A cross-sectional survey of the use of CAM by children was undertaken in the Duchess of Kent Children's Hospital in Hong Kong (March-December 2006). A questionnaire survey concerning the use of CAM was administered to chief caretakers (only the mothers) who accompanied children with neurodevelopmental disabilities followed up in our Neurodevelopmental paediatrics clinics. Four hundred and thirty agreed for interview of which 98 (22.8%) had Autism Spectrum Disorder (ASD). CAM was used in 40.8% for ASD and 21.4% of non-ASD (p < 0.001). We describe the profile of use of CAM in ASD in this part A paper. The three most common type of CAM use was Acupuncture (47.5%), Sensory Integration (42.5%), and Chinese Medicine (30%). About 76.9% of interviewees expected CAM to augment conventional treatment. Although 47.5% used both conventional western medicine and CAM, only 22.4% disclosed the use of CAM to Doctors. The following factors were significantly related to CAM use: father's job and mother's religion. Our frequency of CAM used in children with ASD was lower in Canada (52%) and USA (74%, 92%). The main CAM use in western culture was biological-based therapy whereas acupuncture was the most common CAM used in our locality.
Asunto(s)
Terapia por Acupuntura , Trastorno Autístico/terapia , Terapia Biológica , Terapias Complementarias , Discapacidades del Desarrollo/terapia , Medicina de Hierbas , Medicina Integrativa , Terapia por Acupuntura/ética , Terapia por Acupuntura/métodos , Adolescente , Canadá , Niño , Preescolar , Terapias Complementarias/clasificación , Terapias Complementarias/ética , Terapias Complementarias/métodos , Estudios Transversales , Padre , Femenino , Estudios de Seguimiento , Medicina de Hierbas/ética , Medicina de Hierbas/métodos , Hong Kong , Humanos , Lactante , Medicina Integrativa/ética , Medicina Integrativa/métodos , Masculino , Madres , Ocupaciones , Religión , Encuestas y Cuestionarios , Estados UnidosRESUMEN
Participants are often not informed by investigators who conduct randomised, placebo-controlled acupuncture trials that they may receive a sham acupuncture intervention. Instead, they are told that one or more forms of acupuncture are being compared in the study. This deceptive disclosure practice lacks a compelling methodological rationale and violates the ethical requirement to obtain informed consent. Participants in placebo-controlled acupuncture trials should be provided an accurate disclosure regarding the use of sham acupuncture, consistent with the practice of placebo-controlled drug trials.